We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go: Extended investment: Withheld
Rype addresses the dilemma of choosing between expensive or low-quality office furniture that contributes to carbon emissions and waste. By remanufacturing high-quality used office furniture, Rype offers cost-effective solutions with 80% lower carbon emissions and waste, while creating local jobs. Their mission is to significantly reduce office carbon emissions and costs through sustainable, circular economy practices, including exclusive furniture ranges made from waste materials. Rype's comprehensive services encompass furniture sourcing, remanufacturing, and employing marginalized individuals, contributing to a more environmentally friendly and socially responsible approach to office furnishings.
days to go: Extended investment: Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go: TBC investment: £127,001
PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go: Extended investment: £295,000
GoPower offers comprehensive portable solar energy solutions, designed to save you money and reduce your environmental impact. Their user-friendly solar panels eliminate the need for complex installations, allowing easy setup anywhere. Their portable solar power stations, providing up to 1000w/1280WH at 240v, are perfect for various applications such as home offices, garden rooms, boats, events, and more. With multiple output sockets and versatile charging options including solar panels and mains electricity, GoPower provides a greener and cost-effective energy alternative.
days to go: Extended investment: £10,000
TeaTime deliver fresh and healthy tea blends straight to your door. Simply choose how often you wish to receive your box, weekly or fortnightly and TeaTime will dispatch a selection of 4 of their blends out to you within 48 hours.
days to go: Expired investment: £18,940
Grocemania is an on-demand delivery service which enables consumers to shop for groceries and beverages from their preferred local stores and receive the orders in 1 hour. The company has 60+ shops on-board over London and Brighton, and so far it has completed 3000+ deliveries. Grocemania has been highly commended as an On-Demand Delivery Business at "World Post & Parcel Awards". It has also been featured in many editions like The Grocer, City AM and Talking Retail. The proceeds will be used for sales, marketing and software development.
days to go: Expired investment: £81,735
Fitch Brew Co has developed a new approach to coffee in the form of cold brew coffee. The brand has been designed to target the alcohol industry and work behind the bar with a flavour specifically developed to compliment alcoholic drinks. 
days to go: Expired investment: £148,280
Moody was created after noticing a gap in the market for quality Californian inspired Burgers that they could deliver to their customer's homes. In 2016, burgers entered the top 10 takeaway chart at number 9. Moody offers a credible alternative to pizza and Chinese in a market that is in growth. 
days to go: Expired investment: £157,660
Extra Virgin Avocado Oil for those that live busy lifestyles but enjoy healthy snacking. South Press Co's avocado oil is cold-pressed and derived from the high-grade African avocados. Their oil is available in more than 500 Tesco stores and is sold on Amazon. Since launching in 2016, more than 375,000 bottles have been sold to date. The company is now expanding their business and using their oil in crisps products, dubbed LENTILPOPS®, the first crisps brand in the UK to be made using avocado oil. This new range will contain 60% less fat compared with competing products and will be vegan and gluten, soy and lactose-free. South Press Co will also be launching their brand in the US via an e-commerce platform in January 2019, with distribution to physical retailers by the summer.
days to go: Expired investment: £158,530
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph